JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases
Clinical trial NCT06243159 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06243159
- Sponsor
- Shanxi Bethune Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2026-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.